Recombinant B7-H4 (Alsevalimab Biosimilar) antibody

Catalog No. ABIN7581257

This anti-B7-H4 (Alsevalimab Biosimilar) antibody is a Human Monoclonal antibody detecting B7-H4 (Alsevalimab Biosimilar) in ELISA, FACS, BLI, Func and SPR. Suitable for Human.

Quick Overview for Recombinant B7-H4 (Alsevalimab Biosimilar) antibody (ABIN7581257)

Target: B7-H4 (Alsevalimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This B7-H4 (Alsevalimab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-B7-H4 (Alsevalimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab)

Characteristics: Anti-B7-H4 / VTCN1 Reference Antibody (alsevalimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 104.42 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Conditions: Breast Cancer Ovarian Cancer

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for B7-H4 (Alsevalimab Biosimilar)

Target: B7-H4 (Alsevalimab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: O8E, OV064, B7H4, B7S1, VTCN1, V-set domain-containing T-cell activation inhibitor 1

Molecular Weight: 104.42 kDa

UniProt: Q7Z7D3